Medical Care
Global Alzheimer's Disease Diagnosis Market Research Report 2025
- Jan 17, 26
- ID: 677794
- Pages: 90
- Figures: 86
- Views: 10
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Diagnosis.
The Alzheimer's Disease Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alzheimer's Disease Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Quanterix
Quest Diagnostics
C₂N Diagnostics
Fujirebio
Diadem
Labcorp
Neurocode
Cognitact
EUROIMMUN Medical Diagnostics
Vazyme International
KingMed Diagnostics
Hoyotek
Carrier Biomed
Segment by Type
Neuroimaging Examination
Cerebrospinal Fluid Examination
Peripheral Blood Antibody Examination
Others
Segment by Application
Clinical Diagnosis
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Disease Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Alzheimer's Disease Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alzheimer's Disease Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Quanterix
Quest Diagnostics
C₂N Diagnostics
Fujirebio
Diadem
Labcorp
Neurocode
Cognitact
EUROIMMUN Medical Diagnostics
Vazyme International
KingMed Diagnostics
Hoyotek
Carrier Biomed
Segment by Type
Neuroimaging Examination
Cerebrospinal Fluid Examination
Peripheral Blood Antibody Examination
Others
Segment by Application
Clinical Diagnosis
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Disease Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer's Disease Diagnosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Neuroimaging Examination
1.2.3 Cerebrospinal Fluid Examination
1.2.4 Peripheral Blood Antibody Examination
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Diagnosis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer's Disease Diagnosis Market Perspective (2020-2031)
2.2 Global Alzheimer's Disease Diagnosis Growth Trends by Region
2.2.1 Global Alzheimer's Disease Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Alzheimer's Disease Diagnosis Historic Market Size by Region (2020-2025)
2.2.3 Alzheimer's Disease Diagnosis Forecasted Market Size by Region (2026-2031)
2.3 Alzheimer's Disease Diagnosis Market Dynamics
2.3.1 Alzheimer's Disease Diagnosis Industry Trends
2.3.2 Alzheimer's Disease Diagnosis Market Drivers
2.3.3 Alzheimer's Disease Diagnosis Market Challenges
2.3.4 Alzheimer's Disease Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer's Disease Diagnosis Players by Revenue
3.1.1 Global Top Alzheimer's Disease Diagnosis Players by Revenue (2020-2025)
3.1.2 Global Alzheimer's Disease Diagnosis Revenue Market Share by Players (2020-2025)
3.2 Global Top Alzheimer's Disease Diagnosis Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Alzheimer's Disease Diagnosis Revenue
3.4 Global Alzheimer's Disease Diagnosis Market Concentration Ratio
3.4.1 Global Alzheimer's Disease Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Diagnosis Revenue in 2024
3.5 Global Key Players of Alzheimer's Disease Diagnosis Head office and Area Served
3.6 Global Key Players of Alzheimer's Disease Diagnosis, Product and Application
3.7 Global Key Players of Alzheimer's Disease Diagnosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer's Disease Diagnosis Breakdown Data by Type
4.1 Global Alzheimer's Disease Diagnosis Historic Market Size by Type (2020-2025)
4.2 Global Alzheimer's Disease Diagnosis Forecasted Market Size by Type (2026-2031)
5 Alzheimer's Disease Diagnosis Breakdown Data by Application
5.1 Global Alzheimer's Disease Diagnosis Historic Market Size by Application (2020-2025)
5.2 Global Alzheimer's Disease Diagnosis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Alzheimer's Disease Diagnosis Market Size (2020-2031)
6.2 North America Alzheimer's Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Alzheimer's Disease Diagnosis Market Size by Country (2020-2025)
6.4 North America Alzheimer's Disease Diagnosis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer's Disease Diagnosis Market Size (2020-2031)
7.2 Europe Alzheimer's Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Alzheimer's Disease Diagnosis Market Size by Country (2020-2025)
7.4 Europe Alzheimer's Disease Diagnosis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Disease Diagnosis Market Size (2020-2031)
8.2 Asia-Pacific Alzheimer's Disease Diagnosis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Alzheimer's Disease Diagnosis Market Size by Region (2020-2025)
8.4 Asia-Pacific Alzheimer's Disease Diagnosis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer's Disease Diagnosis Market Size (2020-2031)
9.2 Latin America Alzheimer's Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Alzheimer's Disease Diagnosis Market Size by Country (2020-2025)
9.4 Latin America Alzheimer's Disease Diagnosis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer's Disease Diagnosis Market Size (2020-2031)
10.2 Middle East & Africa Alzheimer's Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Alzheimer's Disease Diagnosis Market Size by Country (2020-2025)
10.4 Middle East & Africa Alzheimer's Disease Diagnosis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Alzheimer's Disease Diagnosis Introduction
11.1.4 Roche Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Quanterix
11.2.1 Quanterix Company Details
11.2.2 Quanterix Business Overview
11.2.3 Quanterix Alzheimer's Disease Diagnosis Introduction
11.2.4 Quanterix Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.2.5 Quanterix Recent Development
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Details
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Alzheimer's Disease Diagnosis Introduction
11.3.4 Quest Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.3.5 Quest Diagnostics Recent Development
11.4 C₂N Diagnostics
11.4.1 C₂N Diagnostics Company Details
11.4.2 C₂N Diagnostics Business Overview
11.4.3 C₂N Diagnostics Alzheimer's Disease Diagnosis Introduction
11.4.4 C₂N Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.4.5 C₂N Diagnostics Recent Development
11.5 Fujirebio
11.5.1 Fujirebio Company Details
11.5.2 Fujirebio Business Overview
11.5.3 Fujirebio Alzheimer's Disease Diagnosis Introduction
11.5.4 Fujirebio Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.5.5 Fujirebio Recent Development
11.6 Diadem
11.6.1 Diadem Company Details
11.6.2 Diadem Business Overview
11.6.3 Diadem Alzheimer's Disease Diagnosis Introduction
11.6.4 Diadem Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.6.5 Diadem Recent Development
11.7 Labcorp
11.7.1 Labcorp Company Details
11.7.2 Labcorp Business Overview
11.7.3 Labcorp Alzheimer's Disease Diagnosis Introduction
11.7.4 Labcorp Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.7.5 Labcorp Recent Development
11.8 Neurocode
11.8.1 Neurocode Company Details
11.8.2 Neurocode Business Overview
11.8.3 Neurocode Alzheimer's Disease Diagnosis Introduction
11.8.4 Neurocode Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.8.5 Neurocode Recent Development
11.9 Cognitact
11.9.1 Cognitact Company Details
11.9.2 Cognitact Business Overview
11.9.3 Cognitact Alzheimer's Disease Diagnosis Introduction
11.9.4 Cognitact Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.9.5 Cognitact Recent Development
11.10 EUROIMMUN Medical Diagnostics
11.10.1 EUROIMMUN Medical Diagnostics Company Details
11.10.2 EUROIMMUN Medical Diagnostics Business Overview
11.10.3 EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Introduction
11.10.4 EUROIMMUN Medical Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.10.5 EUROIMMUN Medical Diagnostics Recent Development
11.11 Vazyme International
11.11.1 Vazyme International Company Details
11.11.2 Vazyme International Business Overview
11.11.3 Vazyme International Alzheimer's Disease Diagnosis Introduction
11.11.4 Vazyme International Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.11.5 Vazyme International Recent Development
11.12 KingMed Diagnostics
11.12.1 KingMed Diagnostics Company Details
11.12.2 KingMed Diagnostics Business Overview
11.12.3 KingMed Diagnostics Alzheimer's Disease Diagnosis Introduction
11.12.4 KingMed Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.12.5 KingMed Diagnostics Recent Development
11.13 Hoyotek
11.13.1 Hoyotek Company Details
11.13.2 Hoyotek Business Overview
11.13.3 Hoyotek Alzheimer's Disease Diagnosis Introduction
11.13.4 Hoyotek Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.13.5 Hoyotek Recent Development
11.14 Carrier Biomed
11.14.1 Carrier Biomed Company Details
11.14.2 Carrier Biomed Business Overview
11.14.3 Carrier Biomed Alzheimer's Disease Diagnosis Introduction
11.14.4 Carrier Biomed Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.14.5 Carrier Biomed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer's Disease Diagnosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Neuroimaging Examination
1.2.3 Cerebrospinal Fluid Examination
1.2.4 Peripheral Blood Antibody Examination
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Diagnosis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer's Disease Diagnosis Market Perspective (2020-2031)
2.2 Global Alzheimer's Disease Diagnosis Growth Trends by Region
2.2.1 Global Alzheimer's Disease Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Alzheimer's Disease Diagnosis Historic Market Size by Region (2020-2025)
2.2.3 Alzheimer's Disease Diagnosis Forecasted Market Size by Region (2026-2031)
2.3 Alzheimer's Disease Diagnosis Market Dynamics
2.3.1 Alzheimer's Disease Diagnosis Industry Trends
2.3.2 Alzheimer's Disease Diagnosis Market Drivers
2.3.3 Alzheimer's Disease Diagnosis Market Challenges
2.3.4 Alzheimer's Disease Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer's Disease Diagnosis Players by Revenue
3.1.1 Global Top Alzheimer's Disease Diagnosis Players by Revenue (2020-2025)
3.1.2 Global Alzheimer's Disease Diagnosis Revenue Market Share by Players (2020-2025)
3.2 Global Top Alzheimer's Disease Diagnosis Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Alzheimer's Disease Diagnosis Revenue
3.4 Global Alzheimer's Disease Diagnosis Market Concentration Ratio
3.4.1 Global Alzheimer's Disease Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Diagnosis Revenue in 2024
3.5 Global Key Players of Alzheimer's Disease Diagnosis Head office and Area Served
3.6 Global Key Players of Alzheimer's Disease Diagnosis, Product and Application
3.7 Global Key Players of Alzheimer's Disease Diagnosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer's Disease Diagnosis Breakdown Data by Type
4.1 Global Alzheimer's Disease Diagnosis Historic Market Size by Type (2020-2025)
4.2 Global Alzheimer's Disease Diagnosis Forecasted Market Size by Type (2026-2031)
5 Alzheimer's Disease Diagnosis Breakdown Data by Application
5.1 Global Alzheimer's Disease Diagnosis Historic Market Size by Application (2020-2025)
5.2 Global Alzheimer's Disease Diagnosis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Alzheimer's Disease Diagnosis Market Size (2020-2031)
6.2 North America Alzheimer's Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Alzheimer's Disease Diagnosis Market Size by Country (2020-2025)
6.4 North America Alzheimer's Disease Diagnosis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer's Disease Diagnosis Market Size (2020-2031)
7.2 Europe Alzheimer's Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Alzheimer's Disease Diagnosis Market Size by Country (2020-2025)
7.4 Europe Alzheimer's Disease Diagnosis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Disease Diagnosis Market Size (2020-2031)
8.2 Asia-Pacific Alzheimer's Disease Diagnosis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Alzheimer's Disease Diagnosis Market Size by Region (2020-2025)
8.4 Asia-Pacific Alzheimer's Disease Diagnosis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer's Disease Diagnosis Market Size (2020-2031)
9.2 Latin America Alzheimer's Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Alzheimer's Disease Diagnosis Market Size by Country (2020-2025)
9.4 Latin America Alzheimer's Disease Diagnosis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer's Disease Diagnosis Market Size (2020-2031)
10.2 Middle East & Africa Alzheimer's Disease Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Alzheimer's Disease Diagnosis Market Size by Country (2020-2025)
10.4 Middle East & Africa Alzheimer's Disease Diagnosis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Alzheimer's Disease Diagnosis Introduction
11.1.4 Roche Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Quanterix
11.2.1 Quanterix Company Details
11.2.2 Quanterix Business Overview
11.2.3 Quanterix Alzheimer's Disease Diagnosis Introduction
11.2.4 Quanterix Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.2.5 Quanterix Recent Development
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Details
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Alzheimer's Disease Diagnosis Introduction
11.3.4 Quest Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.3.5 Quest Diagnostics Recent Development
11.4 C₂N Diagnostics
11.4.1 C₂N Diagnostics Company Details
11.4.2 C₂N Diagnostics Business Overview
11.4.3 C₂N Diagnostics Alzheimer's Disease Diagnosis Introduction
11.4.4 C₂N Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.4.5 C₂N Diagnostics Recent Development
11.5 Fujirebio
11.5.1 Fujirebio Company Details
11.5.2 Fujirebio Business Overview
11.5.3 Fujirebio Alzheimer's Disease Diagnosis Introduction
11.5.4 Fujirebio Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.5.5 Fujirebio Recent Development
11.6 Diadem
11.6.1 Diadem Company Details
11.6.2 Diadem Business Overview
11.6.3 Diadem Alzheimer's Disease Diagnosis Introduction
11.6.4 Diadem Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.6.5 Diadem Recent Development
11.7 Labcorp
11.7.1 Labcorp Company Details
11.7.2 Labcorp Business Overview
11.7.3 Labcorp Alzheimer's Disease Diagnosis Introduction
11.7.4 Labcorp Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.7.5 Labcorp Recent Development
11.8 Neurocode
11.8.1 Neurocode Company Details
11.8.2 Neurocode Business Overview
11.8.3 Neurocode Alzheimer's Disease Diagnosis Introduction
11.8.4 Neurocode Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.8.5 Neurocode Recent Development
11.9 Cognitact
11.9.1 Cognitact Company Details
11.9.2 Cognitact Business Overview
11.9.3 Cognitact Alzheimer's Disease Diagnosis Introduction
11.9.4 Cognitact Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.9.5 Cognitact Recent Development
11.10 EUROIMMUN Medical Diagnostics
11.10.1 EUROIMMUN Medical Diagnostics Company Details
11.10.2 EUROIMMUN Medical Diagnostics Business Overview
11.10.3 EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Introduction
11.10.4 EUROIMMUN Medical Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.10.5 EUROIMMUN Medical Diagnostics Recent Development
11.11 Vazyme International
11.11.1 Vazyme International Company Details
11.11.2 Vazyme International Business Overview
11.11.3 Vazyme International Alzheimer's Disease Diagnosis Introduction
11.11.4 Vazyme International Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.11.5 Vazyme International Recent Development
11.12 KingMed Diagnostics
11.12.1 KingMed Diagnostics Company Details
11.12.2 KingMed Diagnostics Business Overview
11.12.3 KingMed Diagnostics Alzheimer's Disease Diagnosis Introduction
11.12.4 KingMed Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.12.5 KingMed Diagnostics Recent Development
11.13 Hoyotek
11.13.1 Hoyotek Company Details
11.13.2 Hoyotek Business Overview
11.13.3 Hoyotek Alzheimer's Disease Diagnosis Introduction
11.13.4 Hoyotek Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.13.5 Hoyotek Recent Development
11.14 Carrier Biomed
11.14.1 Carrier Biomed Company Details
11.14.2 Carrier Biomed Business Overview
11.14.3 Carrier Biomed Alzheimer's Disease Diagnosis Introduction
11.14.4 Carrier Biomed Revenue in Alzheimer's Disease Diagnosis Business (2020-2025)
11.14.5 Carrier Biomed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Alzheimer's Disease Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Neuroimaging Examination
Table 3. Key Players of Cerebrospinal Fluid Examination
Table 4. Key Players of Peripheral Blood Antibody Examination
Table 5. Key Players of Others
Table 6. Global Alzheimer's Disease Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Alzheimer's Disease Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Alzheimer's Disease Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Alzheimer's Disease Diagnosis Market Share by Region (2020-2025)
Table 10. Global Alzheimer's Disease Diagnosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Alzheimer's Disease Diagnosis Market Share by Region (2026-2031)
Table 12. Alzheimer's Disease Diagnosis Market Trends
Table 13. Alzheimer's Disease Diagnosis Market Drivers
Table 14. Alzheimer's Disease Diagnosis Market Challenges
Table 15. Alzheimer's Disease Diagnosis Market Restraints
Table 16. Global Alzheimer's Disease Diagnosis Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Alzheimer's Disease Diagnosis Market Share by Players (2020-2025)
Table 18. Global Top Alzheimer's Disease Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnosis as of 2024)
Table 19. Ranking of Global Top Alzheimer's Disease Diagnosis Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Alzheimer's Disease Diagnosis Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Alzheimer's Disease Diagnosis, Headquarters and Area Served
Table 22. Global Key Players of Alzheimer's Disease Diagnosis, Product and Application
Table 23. Global Key Players of Alzheimer's Disease Diagnosis, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alzheimer's Disease Diagnosis Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Alzheimer's Disease Diagnosis Revenue Market Share by Type (2020-2025)
Table 27. Global Alzheimer's Disease Diagnosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Alzheimer's Disease Diagnosis Revenue Market Share by Type (2026-2031)
Table 29. Global Alzheimer's Disease Diagnosis Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Alzheimer's Disease Diagnosis Revenue Market Share by Application (2020-2025)
Table 31. Global Alzheimer's Disease Diagnosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Alzheimer's Disease Diagnosis Revenue Market Share by Application (2026-2031)
Table 33. North America Alzheimer's Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Alzheimer's Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Alzheimer's Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Alzheimer's Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Alzheimer's Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Alzheimer's Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Alzheimer's Disease Diagnosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Alzheimer's Disease Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Alzheimer's Disease Diagnosis Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Alzheimer's Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Alzheimer's Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Alzheimer's Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Alzheimer's Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Alzheimer's Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Alzheimer's Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 48. Roche Company Details
Table 49. Roche Business Overview
Table 50. Roche Alzheimer's Disease Diagnosis Product
Table 51. Roche Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Quanterix Company Details
Table 54. Quanterix Business Overview
Table 55. Quanterix Alzheimer's Disease Diagnosis Product
Table 56. Quanterix Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 57. Quanterix Recent Development
Table 58. Quest Diagnostics Company Details
Table 59. Quest Diagnostics Business Overview
Table 60. Quest Diagnostics Alzheimer's Disease Diagnosis Product
Table 61. Quest Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 62. Quest Diagnostics Recent Development
Table 63. C₂N Diagnostics Company Details
Table 64. C₂N Diagnostics Business Overview
Table 65. C₂N Diagnostics Alzheimer's Disease Diagnosis Product
Table 66. C₂N Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 67. C₂N Diagnostics Recent Development
Table 68. Fujirebio Company Details
Table 69. Fujirebio Business Overview
Table 70. Fujirebio Alzheimer's Disease Diagnosis Product
Table 71. Fujirebio Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 72. Fujirebio Recent Development
Table 73. Diadem Company Details
Table 74. Diadem Business Overview
Table 75. Diadem Alzheimer's Disease Diagnosis Product
Table 76. Diadem Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 77. Diadem Recent Development
Table 78. Labcorp Company Details
Table 79. Labcorp Business Overview
Table 80. Labcorp Alzheimer's Disease Diagnosis Product
Table 81. Labcorp Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 82. Labcorp Recent Development
Table 83. Neurocode Company Details
Table 84. Neurocode Business Overview
Table 85. Neurocode Alzheimer's Disease Diagnosis Product
Table 86. Neurocode Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 87. Neurocode Recent Development
Table 88. Cognitact Company Details
Table 89. Cognitact Business Overview
Table 90. Cognitact Alzheimer's Disease Diagnosis Product
Table 91. Cognitact Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 92. Cognitact Recent Development
Table 93. EUROIMMUN Medical Diagnostics Company Details
Table 94. EUROIMMUN Medical Diagnostics Business Overview
Table 95. EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Product
Table 96. EUROIMMUN Medical Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 97. EUROIMMUN Medical Diagnostics Recent Development
Table 98. Vazyme International Company Details
Table 99. Vazyme International Business Overview
Table 100. Vazyme International Alzheimer's Disease Diagnosis Product
Table 101. Vazyme International Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 102. Vazyme International Recent Development
Table 103. KingMed Diagnostics Company Details
Table 104. KingMed Diagnostics Business Overview
Table 105. KingMed Diagnostics Alzheimer's Disease Diagnosis Product
Table 106. KingMed Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 107. KingMed Diagnostics Recent Development
Table 108. Hoyotek Company Details
Table 109. Hoyotek Business Overview
Table 110. Hoyotek Alzheimer's Disease Diagnosis Product
Table 111. Hoyotek Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 112. Hoyotek Recent Development
Table 113. Carrier Biomed Company Details
Table 114. Carrier Biomed Business Overview
Table 115. Carrier Biomed Alzheimer's Disease Diagnosis Product
Table 116. Carrier Biomed Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 117. Carrier Biomed Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Alzheimer's Disease Diagnosis Picture
Figure 2. Global Alzheimer's Disease Diagnosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alzheimer's Disease Diagnosis Market Share by Type: 2024 VS 2031
Figure 4. Neuroimaging Examination Features
Figure 5. Cerebrospinal Fluid Examination Features
Figure 6. Peripheral Blood Antibody Examination Features
Figure 7. Others Features
Figure 8. Global Alzheimer's Disease Diagnosis Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Alzheimer's Disease Diagnosis Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis Case Studies
Figure 11. Research Case Studies
Figure 12. Alzheimer's Disease Diagnosis Report Years Considered
Figure 13. Global Alzheimer's Disease Diagnosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Alzheimer's Disease Diagnosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Alzheimer's Disease Diagnosis Market Share by Region: 2024 VS 2031
Figure 16. Global Alzheimer's Disease Diagnosis Market Share by Players in 2024
Figure 17. Global Alzheimer's Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Alzheimer's Disease Diagnosis Revenue in 2024
Figure 19. North America Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Alzheimer's Disease Diagnosis Market Share by Country (2020-2031)
Figure 21. United States Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Alzheimer's Disease Diagnosis Market Share by Country (2020-2031)
Figure 25. Germany Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Alzheimer's Disease Diagnosis Market Share by Region (2020-2031)
Figure 33. China Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Alzheimer's Disease Diagnosis Market Share by Country (2020-2031)
Figure 41. Mexico Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Alzheimer's Disease Diagnosis Market Share by Country (2020-2031)
Figure 45. Turkey Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 49. Quanterix Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 50. Quest Diagnostics Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 51. C₂N Diagnostics Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 52. Fujirebio Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 53. Diadem Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 54. Labcorp Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 55. Neurocode Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 56. Cognitact Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 57. EUROIMMUN Medical Diagnostics Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 58. Vazyme International Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 59. KingMed Diagnostics Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 60. Hoyotek Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 61. Carrier Biomed Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Alzheimer's Disease Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Neuroimaging Examination
Table 3. Key Players of Cerebrospinal Fluid Examination
Table 4. Key Players of Peripheral Blood Antibody Examination
Table 5. Key Players of Others
Table 6. Global Alzheimer's Disease Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Alzheimer's Disease Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Alzheimer's Disease Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Alzheimer's Disease Diagnosis Market Share by Region (2020-2025)
Table 10. Global Alzheimer's Disease Diagnosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Alzheimer's Disease Diagnosis Market Share by Region (2026-2031)
Table 12. Alzheimer's Disease Diagnosis Market Trends
Table 13. Alzheimer's Disease Diagnosis Market Drivers
Table 14. Alzheimer's Disease Diagnosis Market Challenges
Table 15. Alzheimer's Disease Diagnosis Market Restraints
Table 16. Global Alzheimer's Disease Diagnosis Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Alzheimer's Disease Diagnosis Market Share by Players (2020-2025)
Table 18. Global Top Alzheimer's Disease Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnosis as of 2024)
Table 19. Ranking of Global Top Alzheimer's Disease Diagnosis Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Alzheimer's Disease Diagnosis Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Alzheimer's Disease Diagnosis, Headquarters and Area Served
Table 22. Global Key Players of Alzheimer's Disease Diagnosis, Product and Application
Table 23. Global Key Players of Alzheimer's Disease Diagnosis, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alzheimer's Disease Diagnosis Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Alzheimer's Disease Diagnosis Revenue Market Share by Type (2020-2025)
Table 27. Global Alzheimer's Disease Diagnosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Alzheimer's Disease Diagnosis Revenue Market Share by Type (2026-2031)
Table 29. Global Alzheimer's Disease Diagnosis Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Alzheimer's Disease Diagnosis Revenue Market Share by Application (2020-2025)
Table 31. Global Alzheimer's Disease Diagnosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Alzheimer's Disease Diagnosis Revenue Market Share by Application (2026-2031)
Table 33. North America Alzheimer's Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Alzheimer's Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Alzheimer's Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Alzheimer's Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Alzheimer's Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Alzheimer's Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Alzheimer's Disease Diagnosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Alzheimer's Disease Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Alzheimer's Disease Diagnosis Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Alzheimer's Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Alzheimer's Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Alzheimer's Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Alzheimer's Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Alzheimer's Disease Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Alzheimer's Disease Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 48. Roche Company Details
Table 49. Roche Business Overview
Table 50. Roche Alzheimer's Disease Diagnosis Product
Table 51. Roche Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Quanterix Company Details
Table 54. Quanterix Business Overview
Table 55. Quanterix Alzheimer's Disease Diagnosis Product
Table 56. Quanterix Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 57. Quanterix Recent Development
Table 58. Quest Diagnostics Company Details
Table 59. Quest Diagnostics Business Overview
Table 60. Quest Diagnostics Alzheimer's Disease Diagnosis Product
Table 61. Quest Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 62. Quest Diagnostics Recent Development
Table 63. C₂N Diagnostics Company Details
Table 64. C₂N Diagnostics Business Overview
Table 65. C₂N Diagnostics Alzheimer's Disease Diagnosis Product
Table 66. C₂N Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 67. C₂N Diagnostics Recent Development
Table 68. Fujirebio Company Details
Table 69. Fujirebio Business Overview
Table 70. Fujirebio Alzheimer's Disease Diagnosis Product
Table 71. Fujirebio Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 72. Fujirebio Recent Development
Table 73. Diadem Company Details
Table 74. Diadem Business Overview
Table 75. Diadem Alzheimer's Disease Diagnosis Product
Table 76. Diadem Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 77. Diadem Recent Development
Table 78. Labcorp Company Details
Table 79. Labcorp Business Overview
Table 80. Labcorp Alzheimer's Disease Diagnosis Product
Table 81. Labcorp Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 82. Labcorp Recent Development
Table 83. Neurocode Company Details
Table 84. Neurocode Business Overview
Table 85. Neurocode Alzheimer's Disease Diagnosis Product
Table 86. Neurocode Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 87. Neurocode Recent Development
Table 88. Cognitact Company Details
Table 89. Cognitact Business Overview
Table 90. Cognitact Alzheimer's Disease Diagnosis Product
Table 91. Cognitact Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 92. Cognitact Recent Development
Table 93. EUROIMMUN Medical Diagnostics Company Details
Table 94. EUROIMMUN Medical Diagnostics Business Overview
Table 95. EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Product
Table 96. EUROIMMUN Medical Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 97. EUROIMMUN Medical Diagnostics Recent Development
Table 98. Vazyme International Company Details
Table 99. Vazyme International Business Overview
Table 100. Vazyme International Alzheimer's Disease Diagnosis Product
Table 101. Vazyme International Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 102. Vazyme International Recent Development
Table 103. KingMed Diagnostics Company Details
Table 104. KingMed Diagnostics Business Overview
Table 105. KingMed Diagnostics Alzheimer's Disease Diagnosis Product
Table 106. KingMed Diagnostics Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 107. KingMed Diagnostics Recent Development
Table 108. Hoyotek Company Details
Table 109. Hoyotek Business Overview
Table 110. Hoyotek Alzheimer's Disease Diagnosis Product
Table 111. Hoyotek Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 112. Hoyotek Recent Development
Table 113. Carrier Biomed Company Details
Table 114. Carrier Biomed Business Overview
Table 115. Carrier Biomed Alzheimer's Disease Diagnosis Product
Table 116. Carrier Biomed Revenue in Alzheimer's Disease Diagnosis Business (2020-2025) & (US$ Million)
Table 117. Carrier Biomed Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Alzheimer's Disease Diagnosis Picture
Figure 2. Global Alzheimer's Disease Diagnosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alzheimer's Disease Diagnosis Market Share by Type: 2024 VS 2031
Figure 4. Neuroimaging Examination Features
Figure 5. Cerebrospinal Fluid Examination Features
Figure 6. Peripheral Blood Antibody Examination Features
Figure 7. Others Features
Figure 8. Global Alzheimer's Disease Diagnosis Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Alzheimer's Disease Diagnosis Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis Case Studies
Figure 11. Research Case Studies
Figure 12. Alzheimer's Disease Diagnosis Report Years Considered
Figure 13. Global Alzheimer's Disease Diagnosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Alzheimer's Disease Diagnosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Alzheimer's Disease Diagnosis Market Share by Region: 2024 VS 2031
Figure 16. Global Alzheimer's Disease Diagnosis Market Share by Players in 2024
Figure 17. Global Alzheimer's Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Alzheimer's Disease Diagnosis Revenue in 2024
Figure 19. North America Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Alzheimer's Disease Diagnosis Market Share by Country (2020-2031)
Figure 21. United States Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Alzheimer's Disease Diagnosis Market Share by Country (2020-2031)
Figure 25. Germany Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Alzheimer's Disease Diagnosis Market Share by Region (2020-2031)
Figure 33. China Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Alzheimer's Disease Diagnosis Market Share by Country (2020-2031)
Figure 41. Mexico Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Alzheimer's Disease Diagnosis Market Share by Country (2020-2031)
Figure 45. Turkey Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Alzheimer's Disease Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 49. Quanterix Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 50. Quest Diagnostics Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 51. C₂N Diagnostics Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 52. Fujirebio Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 53. Diadem Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 54. Labcorp Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 55. Neurocode Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 56. Cognitact Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 57. EUROIMMUN Medical Diagnostics Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 58. Vazyme International Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 59. KingMed Diagnostics Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 60. Hoyotek Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 61. Carrier Biomed Revenue Growth Rate in Alzheimer's Disease Diagnosis Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232